Mette Lise Lousdal
Overview
Explore the profile of Mette Lise Lousdal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lousdal M, Lash T, Flanders W, Brookhart M, Kristiansen I, Vedsted P, et al.
Epidemiology
. 2025 Jan;
PMID: 39855264
Background: Improvements in breast cancer therapy since the randomized controlled trials of mammography screening might have reduced the screening benefit. Most observational studies of mammography effectiveness would be confounded by...
2.
Momen N, Beck C, Lousdal M, Agerbo E, McGrath J, Pedersen C, et al.
JAMA Psychiatry
. 2024 Nov;
82(2):161-170.
PMID: 39602130
Importance: Research suggests an increase in mental disorder incidence in recent years, but this trend remains unexplained, and there is a lack of large studies based on a representative sample...
3.
Rossell E, Lousdal M, Viuff J, Stovring H
Scand J Public Health
. 2024 Oct;
:14034948241288136.
PMID: 39462832
Aims: To investigate the potential lead time bias of the evaluation model (extended follow-up for women diagnosed with breast cancer) used to evaluate mammography screening in a recent Danish study....
4.
Lousdal M, Plana-Ripoll O
Eur Neuropsychopharmacol
. 2023 Oct;
79:1-3.
PMID: 37864953
No abstract available.
5.
Rossell E, Bornhoft L, Lousdal M, Stovring H
Eur J Public Health
. 2021 Jan;
31(3):597-601.
PMID: 33462621
Background: Relative reduction in breast cancer mortality is the preferred outcome measure for evaluation of mammography screening. However, mean survival time has been advocated as a better and more intuitive...
6.
Lousdal M, Lash T, Flanders W, Brookhart M, Kristiansen I, Kalager M, et al.
Int J Epidemiol
. 2020 Mar;
49(3):1032-1042.
PMID: 32211885
Background: When comparing mammography-screening participants and non-participants, estimates of reduction in breast-cancer mortality may be biased by poor baseline comparability. We used negative controls to detect uncontrolled confounding. Methods: We...
7.
Johansen E, Lousdal M, Skriver M, Vaeth M, Kristiansen I, Stovring H
Med Decis Making
. 2019 Mar;
39(3):228-238.
PMID: 30834808
Background: Gain in mean survival time from new cancer treatments is a core component of cost-effectiveness analyses frequently used by payers for reimbursement decisions. Due to limited follow-up time, clinical...
8.
Moller M, Lousdal M, Kristiansen I, Stovring H
Int J Cancer
. 2018 Aug;
144(4):697-706.
PMID: 30144028
We aimed to estimate the effect of organized mammography screening on incidence-based breast cancer mortality by comparing changes in mortality among women eligible for screening to concurrent changes in younger...
9.
Lousdal M
Emerg Themes Epidemiol
. 2018 Feb;
15:1.
PMID: 29387137
The instrumental variable method has been employed within economics to infer causality in the presence of unmeasured confounding. Emphasising the parallels to randomisation may increase understanding of the underlying assumptions...
10.
Loberg M, Lousdal M, Bretthauer M, Kalager M
Breast Cancer Res
. 2015 May;
17:63.
PMID: 25928287
Mammography screening for breast cancer is widely available in many countries. Initially praised as a universal achievement to improve women's health and to reduce the burden of breast cancer, the...